CHRONOS

Dupilumab maintains long-term benefits in atopic dermatitis
Dupilumab maintains long-term benefits in atopic dermatitisLong-term data for dupilumab in atopic dermatitis revealed at the American Academy of Dermatology (AAD) 75th Annual Meeting reflect safety, rapid relief of troublesome symptoms and a long-lived response in keeping with the drug’s breakthrough status, experts told Dermatology Times.